Anette
Anette Aesoy, Skien NO
Patent application number | Description | Published |
---|---|---|
20090242468 | System for Controlling the Concentration of a Detrimental Substance in a Sewer Network - The invention relates to a system for controlling the concentration of a detrimental substance, in particular H | 10-01-2009 |
Anette Arnold, Schriesheim DE
Patent application number | Description | Published |
---|---|---|
20140196421 | UREA FILTER MATERIAL - A urea filter material may have a base layer, a cover layer and a filter layer arranged between the base layer and the cover layer, wherein all of the layers are formed from polypropylene non-woven fabric. | 07-17-2014 |
Anette Berni, Kashofen DE
Patent application number | Description | Published |
---|---|---|
20090141359 | PLASTIC FILM WITH A MULTILAYERED INTERFERENCE COATING - A polymer film with an optical interference system. The optical interference system comprises at least two layers of different refractive index, which layers comprise nanoscale inorganic particles having organic surface groups that are polymerizable and/or polycondensable. The layers are at least partially crosslinked through the organic surface groups. | 06-04-2009 |
Anette Brunner-Schwarz, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20090082255 | Acidic Insulin Preparations Having Improved Stability - The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range. | 03-26-2009 |
20100216692 | Acidic Insulin Preparations Having Improved Stability - The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range. | 08-26-2010 |
20120283179 | PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST AND METHIONINE - A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate. | 11-08-2012 |
Anette Bunka, Eggenstein-Leopoldshafen DE
Patent application number | Description | Published |
---|---|---|
20150192197 | Gear Unit Having a Shaft - A gear unit having a shaft, particularly an input shaft, a fan impeller being joined in rotatably fixed manner to the shaft, a fan cowl, which at least partially surrounds the fan impeller, being mounted on the gear housing, a separating plate for separating the pressure chamber of the fan from the suction chamber of the fan being joined to the fan cowl, the separating plate having an air inlet for the fan impeller and being disposed on the side of the fan impeller facing away axially from the gear unit. | 07-09-2015 |
Anette Doettinger, Eningen DE
Patent application number | Description | Published |
---|---|---|
20140248715 | METHOD FOR DETECTING BIOMOLECULES - A method of detecting biomolecules present in a complex biological sample includes a) separating the biological sample into fractions according to at least one physical property of the biomolecules; and b) specifically detecting biomolecules present in the fractions using at least one solid-phase-based, immunological detection method including immobilizing the biomolecules from the individual fractions on microsphere populations specific for each fraction and distinguishable from one another. | 09-04-2014 |
Anette Gundertofte, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20100120743 | 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds - A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome. | 05-13-2010 |
Anette Heijnesson-Hulten, Lerum SE
Patent application number | Description | Published |
---|---|---|
20100112351 | METHOD FOR PREPARING MICROFIBRILLAR POLYSACCHARIDE - The present invention relates to a method of preparing microfibrillar polysaccharide comprising treating a polysaccharide in an aqueous suspension comprising an oxidant and at least one transition metal, mechanically delaminating said polysaccharide such that microfibrillar polysaccharide is formed. The invention also relates to microfibrillar polysaccharide obtainable by the method. | 05-06-2010 |
Anette Høj, Tjele DK
Patent application number | Description | Published |
---|---|---|
20100099104 | GENETIC TEST FOR THE IDENTIFICATION OF CARRIERS OF COMPLEX VERTEBRAL MALFORMATIONS IN CATTLE - Genetic markets for identifying bovine carriers of complex vertebral malformation (CVM) disease gene are described. The genetic markers, including the microsatellite markers, BM4129, INRAA003, BMS2790, ILSTS029, INRA123, BM220, HUJ246, BMS862, BMS937, BL1048, BMS2095 and BMS1266 and the bovine SLC35A3 gene, are located on bovine chromosome BTA3. The G/T polymorphism at position 559 of the bovine SLC35A3 gene is identified as being causative and diagnostic for CVM in cattle. | 04-22-2010 |
Anette Holtmann, Ballerup DK
Patent application number | Description | Published |
---|---|---|
20090143232 | METHOD FOR SYNTHESISING TEMPLATED MOLECULES - The invention relates to a method for synthesizing templated molecules attached to the templated which directed the synthesis thereof. The method involves a template, a scaffold functional entity and a functional entity attached to a building block, which, in turn, is attached the template. The scaffold functional entity and the functional entity of the building block are both provided with complementary dimerization domains allowing the functional entities to come into close proximity when the complementary domains interact with to each other. The method may be used for generating libraries of templated molecules which may be selected for biological activity. | 06-04-2009 |
20090264300 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES - Disclosed is a method for obtaining a bifunctional complex comprising a molecule linked to a single stranded identifier oligonucleotide, wherein a nascent bifunctional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is a) reacted at the chemical reaction site with one or more reactants, and b) reacted enzymatically at the priming site with one or more tag(s) identifying the reactant(s). | 10-22-2009 |
20100016177 | TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES - The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be screened for e.g. therapeutic activity. | 01-21-2010 |
20110230419 | IAP BINDING COMPOUNDS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the treatment of proliferative diseases, such as cancer, for promoting apoptosis in proliferating cells, and for sensitizing cells to inducers of apoptosis. The present invention furthermore provides a polymeric compound of formulas (VI) or (VII), comprising either at least two monomeric units of compounds of formula (I), or at least one monomeric unit of a compound of formula (I) and an entity E. The present invention further relates to pharmaceutical compositions comprising said compounds of formulas (I), (VI), and (VII) and the use of said compounds in medicine. | 09-22-2011 |
20130040823 | METHOD FOR THE SYNTHESIS OF A BIFUNCTIONAL COMPLEX - Disclosed is a method for obtaining a bifunctional complex comprising a display molecule part and a coding part, wherein a nascent bifuntional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is reacted at the chemical reaction site with one or more reactants, and provided with respective tag(s) identifying the reactant(s) at the priming site is using one or more enzymes. | 02-14-2013 |
20150252360 | METHOD FOR SYNTHESISING TEMPLATED MOLECULES - The invention relates to a method for synthesising templated molecules attached to the templated which directed the synthesis thereof. The method involves a template, a scaffold functional entity and a functional entity attached to a building block, which, in turn, is attached the template. The scaffold functional entity and the functional entity of the building block are both provided with complementary dimerization domains allowing the functional entities to come into close proximity when the complementary domains interact with to each other. The method may be used for generating libraries of templated molecules which may be selected for biological activity. | 09-10-2015 |
Anette Koenigsdorfer, Ilvesheim DE
Patent application number | Description | Published |
---|---|---|
20080292642 | Crystalline anti-human IL-12 antibodies - The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions. | 11-27-2008 |
20100034823 | Crystalline anti-hTNFalpha antibodies - The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions. | 02-11-2010 |
20120177704 | CRYSTALLINE ANTI-HUMAN IL-12 ANTIBODIES - The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions. | 07-12-2012 |
20120251550 | Crystalline anti-hTNFalpha antibodies - The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions. | 10-04-2012 |
20130309309 | CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES - The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions. | 11-21-2013 |
20140017256 | CRYSTALLINE ANTI-HUMAN IL-12 ANTIBODIES - The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions. | 01-16-2014 |
20150183863 | CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES - The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions. | 07-02-2015 |
Anette Müllertz, Charlottenlund DK
Patent application number | Description | Published |
---|---|---|
20120232141 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF - Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride. | 09-13-2012 |
Anette Müllertz, Chartottenlund DK
Patent application number | Description | Published |
---|---|---|
20140017308 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE, A FREE FATTY ACID, AND A STATIN - Compositions comprising a fatty acid oil mixture, at least one free fatty acid, and at least one statin or pharmaceutically acceptable salt, hydrate, solvate, or complex thereof, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. | 01-16-2014 |
Anette Nilsson, Stenungsund SE
Patent application number | Description | Published |
---|---|---|
20150305256 | POLYMER COMPOSITION COMPRISING A BLEND OF A MULTIMODAL POLYETHYLENE AND A FURTHER ETHYLENE POLYMER SUITABLE FOR THE PRODUCTION OF A DRIP IRRIGATION PIPE - The present application relates to a polymer composition as defined in claims comprising (A) a polymer base resin, which comprises a blend of (A-1) a multimodal ethylene polymer and (A-2) an ethylene polymer, and carbon black, a drip irrigation pipe comprising said polymer composition, a process for producing said drip irrigation pipe, pellets comprising said polymer composition and the use of said polymer composition for producing said drip irrigation pipe. | 10-29-2015 |
Anette Nordskog, Sandefjord NO
Patent application number | Description | Published |
---|---|---|
20100024133 | TRIS(HETEROCYCLYL) METAL COMPLEXES, WASHING AND CLEANING AGENTS CONTAINING THE SAME, AND USE AS BLEACH CATALYSTS - Tris(heterocyclyl)-metal complexes and the use thereof as bleach catalysts are described. | 02-04-2010 |
20100029540 | BIHETEROARYL METAL COMPLEXES AS BLEACH CATALYSTS - Biheteroaryl metal complexes and the use thereof as bleach catalysts are described. | 02-04-2010 |
20100048447 | BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS - Bis(hydroxyquinoline)-metal complexes and the use thereof as bleach catalysts are described. | 02-25-2010 |
20110119837 | Washing Agent That Is Gentile on Textiles - Reduction of damage to textiles caused when bleach active catalysts are used when washing the textiles, without influencing bleaching performance. The invention relates to a method for washing textiles in the presence of a peroxygenated bleaching agent and a bleach boosting transition metal complex, wherein the method is carried out when water hardness is between 0° dH-3° dH. | 05-26-2011 |
20120005839 | GENTLE BLEACHING AGENT - An agent, and a method that uses the agent, reduces the damage to material containing cellulose during the bleaching thereof, by using a bleaching agent containing peroxygen, a bleach-enhancing transition metal complex, and creatine. | 01-12-2012 |
20120015860 | GENTLE BLEACHING AGENT - The aim of the invention is reduce the damage to material containing cellulose during the bleaching thereof, by using bleaching catalysts, without significantly affecting the bleaching performance. This is achieved essentially by a method for the bleach treatment of material containing cellulose in the presence of a bleaching agent containing peroxygen and a bleach-enhancing transition metal complex, said method being carried out in the presence of a saccharide polymer carrying carboxy groups. | 01-19-2012 |
20120077726 | GENTLE BLEACHING AGENT - The aim of the invention is to reduce the damage to cellulosic material during the bleaching treatment of cellulosic material by using catalysts with bleaching activity, without significantly impacting the bleaching performance in the process. This was achieved largely by way of a method for bleaching cellulosic material in the presence of a peroxygen-containing bleaching agent and a bleach-boosting transition metal complex, which is carried out in the presence of spherical polyelectrolyte brushes. The spherical polyelectrolyte brushes preferably contain the transition metal complex in a colloidally bound manner. | 03-29-2012 |
20120264668 | DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU - A bleach catalyst includes a complex of Fe—, Mo—, Mn— and/or W with a ligand having a skeleton of formula (I). | 10-18-2012 |
20120264670 | DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU - The aim of the invention is to improve the cleaning power of detergents and cleaning agents, especially with regard to bleachable stains, while avoiding any damage to the textile treated with said detergents and cleaning agents. For this purpose, a bleach catalyst in the form of a complex of Fe—, Mo—, Mn— and/or W with a ligand having a skeleton of formula (I) is used. | 10-18-2012 |
Anette Nordskog, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20090156454 | GRANULATES FOR A SENSITIVE WASHING- OR CLEANING AGENT CONTAINING MATERIAL - Granulates for washing- or cleaning agents, containing (a) a sensitive washing- or cleaning agent component, (b) an adsorbent carrier material, (c) a binder that is different from (b), and (d) optional additional substances that are different from (b) and (c). The granulates display a disintegration index of at least 50 percent after 24 hours. These granulates are particularly suited for use in liquid- or gel-forming aqueous washing- or cleaning agents. Also, a procedure for the manufacture of such granulates, in regards to washing- or cleaning agents. | 06-18-2009 |
Anette Partheil, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20110113867 | DEVICE FOR RECEIVING A SOLID IN A MEASURING CELL - A device for the accommodation of a solid in a measuring cell ( | 05-19-2011 |
Anette Sallwey, Dreieich DE
Patent application number | Description | Published |
---|---|---|
20110311465 | Oxidizing Composition for the Treatment of Keratin Fibers - The present invention relates to an oxidizing composition for treatment of keratin fibers comprising a combination of; (a) at least one anionic associative copolymer, (b) at least one anionic non associative copolymer; (c) at least one peroxide agent; (d) at least one persulfate agent; (e) at least on alkalizing agent; and (f) a carrier medium suitable for hair treatment. | 12-22-2011 |
20120288459 | Oxidizing Composition for the Treatment of Keratin Fibers - The present invention relates to an oxidizing composition for treatment of keratin fibers comprising a combination of; (a) at least one anionic associative copolymer, (b) at least one anionic non associative copolymer; (c) at least one peroxide agent; (d) at least one persulfate agent; (e) at least on alkalizing agent; and (f) a carrier medium suitable for hair treatment. The oxidizing composition described is suitable for composition used in conventional hair treatments such as dyeing, bleaching, and permanent waving or relaxing/straightening of the keratinous fibers, particularly human hair, requiring an oxidizing composition. | 11-15-2012 |
Anette Sandegard, Malmo SE
Patent application number | Description | Published |
---|---|---|
20080287060 | Electronic Equipment for a Wireless Communication System and Method for Operating an Electronic Equipment for a Wireless Communication System - The present invention relates to an electronic equipment for a wireless communication system comprising a near field interface ( | 11-20-2008 |
Anette Sandegard, Anette SE
Patent application number | Description | Published |
---|---|---|
20130196599 | ELECTRONIC EQUIPMENT FOR A WIRELESS COMMUNICATION SYSTEM AND METHOD FOR OPERATING AN ELECTRONIC EQUIPMENT FOR A WIRELESS COMMUNICATION SYSTEM - The present invention relates to an electronic equipment for a wireless communication system comprising a near field interface ( | 08-01-2013 |
Anette Sommer, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090076098 | METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREATMENT OF A PATHOLOGICAL DISORDER BY EPOTHILONES - The invention provides methods, kits and compounds for determining the potential responsiveness of a subject suffering from a pathological disorder, including non-small cell lung cancer (NSCLC), to treatment with an epothilone by analyzing the gene expression profile and/or certain molecular markers in a sample obtained from said subject. The invention further relates to methods, compounds and uses of said compounds for treating subjects suffering from said pathologic disorder, optionally in combination with other therapeutic agents. Also provided are genes and/or proteins encoded by them whose expression level have been determined to differ between epothilone responders and epothilone non-responders. | 03-19-2009 |
20150023989 | NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF - The present application relates to new antibody drug conjugates (ADCs) of N,N dialkylauristatins directed against the target FGFR2, drug metabolites of said ADCs, a method for producing said ADCs, the use of said ADCs for the treatment and/or prevention of illnesses as well as the use of said ADCs for producing pharmaceuticals for the treatment and/or prevention of illnesses, particularly of hyperproliferative and/or angiogenic diseases such as carcinosis. Such treatments can be carried out as monotherapy or in combination with other pharmaceuticals or additional therapeutic measures. | 01-22-2015 |
Anette Stryhn, Virum DK
Patent application number | Description | Published |
---|---|---|
20110020384 | THERAPEUTIC TB VACCINE - Therapeutic vaccines comprising polypeptides expressed during the latent stage of mycobacteria infection are provided, as are multiphase vaccines, and methods for treating and preventing | 01-27-2011 |
20130149324 | THERAPEUTIC TB VACCINE - Therapeutic vaccines comprising polypeptides expressed during the latent stage of mycobacteria infection are provided, as are multiphase vaccines, and methods for treating and preventing tuberculosis. | 06-13-2013 |
Anette Sunna, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20150160845 | BREATHING APPARATUS AND METHOD FOR USER INTERACTION THEREWITH - A breathing apparatus has one or more electronic processors and a touch screen communicatively coupled to at least one of the processors. The processor is configured to provide a user interface on the touch screen for modification of at least one operational parameter of the breathing apparatus. The user interface includes at least two touch sensitive display areas on the display area of the touch screen for modification of the operational parameter by an operator of the breathing apparatus. Each of the two touch sensitive display areas is dedicated for different types of user interaction, i.e. different user interaction modes are provided for by each of the two different display areas. | 06-11-2015 |
20150177955 | BREATHING APPARATUS SYSTEM, METHOD AND COMPUTER-READABLE MEDIUM - In a breathing apparatus system, a method and a computer-readable medium, the system including a breathing apparatus having a display, a memory unit, and a processing unit in operative communication with the display and the memory unit; and said processing unit is configured to provide multiple selectable screen views, and to provide, upon selection of a screen view, on at least a portion of the display, a preview of the selected screen view. The system is more user-friendly than known systems and easier to overview during e.g. set-up of a new view. | 06-25-2015 |
20150193585 | SYSTEM WITH BREATHING APPARATUS AND TOUCH SCREEN - A system includes a breathing apparatus, a touch screen unit and a processing unit. A first content is displayed at a first screen location of the touch screen. Upon a user input, comprising a gesture of one or more gestures, at the first screen location, a second content related to the first content is selected and displayed in dependence of the gesture and the first content. The first content ( | 07-09-2015 |
20150199095 | BREATHING APPARATUS HAVING A DISPLAY WITH USER SELECTABLE BACKGROUND - A breathing apparatus and system include a breathing apparatus having a display, an internal memory unit, and a processing unit, and optionally an interface for connecting at least an external memory unit to the apparatus; optionally an external memory unit connectable to the breathing apparatus via the interface; wherein the processing unit is in operative communication with the display, the internal memory unit, and/or the external memory unit when connected to the apparatus via the interface, and the processing unit is configured to provide on at least a portion of the display, a user selectable background stored on at least one of the internal and/or external memory unit, such as a background image, or a background color different than a factory default background color that is not selectable by a user. | 07-16-2015 |
Anette Thyberg, Stenungsund SE
Patent application number | Description | Published |
---|---|---|
20090076299 | PHOSPHATED ALCANOL, ITS USE AS A HYDROTROPE AND CLEANING COMPOSITION CONTAINING THE COMPOUND - The present invention relates to the use of phosphated 2-propylheptanol or a phosphated 2-propylheptanol alkoxylate as a hydrotrope in aqueous alkaline solutions for a C | 03-19-2009 |
20130298948 | Composition for Cleaning of Hard Surfaces - The invention relates to the use of an alkaline aqueous composition comprising a) an amine oxide b) a nonionic surfactant, not being an amine oxide, and c) a cationic hydrotrope having the formula (I), where R=C | 11-14-2013 |
20150126429 | Use Of An Ethoxylated Alkanolamide As A Hydrotrope For An Alkylene Oxide Adduct Of An Alcohol - The present invention relates to the use of an ethoxylated alkanolamide as a hydrotrope for an alkyleneoxide adduct of an alcoholin aqueous solutions. It also relates to a composition comprising said ethoxylated alkanolamide and said alkyleneoxide adduct of an alcohol, and the use of this composition for the cleaning of hard surfaces or for the treatment of a plant. | 05-07-2015 |
Anette Tybirk, Hinnerup DK
Patent application number | Description | Published |
---|---|---|
20130108769 | BUTTER-DERIVED SPREAD AND A METHOD OF PRODUCING IT | 05-02-2013 |
Anette Wagner, Walsrode DE
Patent application number | Description | Published |
---|---|---|
20140326423 | WATER-DISINTEGRATABLE NON-WOVEN FIBROUS SHEET - A water-disintegratable non-woven sheet comprising fibers bound by a water-soluble cellulose ether can be produced laying fibers to a base sheet, b) contacting the base sheet with a water-based composition comprising a water-soluble cellulose ether having a viscosity of up 500 mPa·s, measured as a 2 weight percent solution in water at 20° C. using a Haake Viscotester VT550 with a cylinder system, cup MV, at 2.55 s | 11-06-2014 |
Anette Weyergang, Oslo NO
Patent application number | Description | Published |
---|---|---|
20110293575 | PHOTOCHEMICAL INTERNALISATION OF KINASE INHIBITORS - The present invention relates to a method for enhancing the activity of kinase inhibitors in target cells, and more specifically for enhancing the activity of tyrosine kinase inhibitors (TKIs), said method comprising contacting a cell with a kinase inhibitor and a photosensitizing agent and irradiating said cell with light of a wavelength effective to activate the photosensitizing agent, and to the use of this method for enhancing the effects of kinase inhibitors or kinase inhibitor-based drugs in particular to achieve cell death, for example, in cancer treatment and other diseases or conditions in which kinase inhibitors, such as TKIs, have a beneficial effect. | 12-01-2011 |
Anette Zur Mühlen, Krefeld DE
Patent application number | Description | Published |
---|---|---|
20100288792 | DISPENSER, IN PARTICULAR, METERING DISPENSER - The invention concerns a dispenser, in particular for semi-solid or liquid systems, with a housing to hold a dispenser unit which is formed by a storage container, a metering unit ( | 11-18-2010 |
Anette Zur Mühlen, Krefeld DE
Patent application number | Description | Published |
---|---|---|
20100288792 | DISPENSER, IN PARTICULAR, METERING DISPENSER - The invention concerns a dispenser, in particular for semi-solid or liquid systems, with a housing to hold a dispenser unit which is formed by a storage container, a metering unit ( | 11-18-2010 |